Periarticular Multimodal Drug Injections in Total Knee Arthroplasty
Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether periarticular multimodal drug injection
(PMDI) would provide additional benefits in patients after total knee arthroplasty (TKA) for
whom contemporary pain control protocols using the continuous femoral nerve block,
intra-venous patient controlled analgesia (IV-PCA)and preemptive oral medications. We
hypothesized that PMDI would reduce pain level and consumption of PCA and acute pain rescuer
and would provide better functional recovery and patient satisfaction. We also hypothesized
that the incidence of side effects and complications of the PMDI would be similar to the
No-PMDI.